Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Cancer Management

Cancer Pain Management

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

What is Cancer?

Myc Mutations and Cancer

What is Immunochemotherapy?

Secondary Brain Cancer

What is the Tumor Microenvironment?

Is Cancer a Metabolic Disorder?

CDK9 and Cancer

British Pioneers in Cancer Biology

See more featured articles »

What is Tumorigenesis?

Hot vs Cold: the differences between tumor types

Exploiting Enzymes in Cancer Diagnosis and Therapy

Cancer Diagnosis

Targeted Cancer Therapies

Cancer History

Cancer Screening Considerations: Balancing the Benefits and Risks

Microfluidic cancer treatment screen combined with flow cytometry

What is Merkel Cell Carcinoma?

Cancer Glossary

Acidosis and Tumor Progression

Cancer Classification

Overview of Cell Viability and Cytotoxicity

What is Cancer of Unknown Primary?

Effects of Social and Economic Deprivation on Cancer Mortality

Secondary Lung Cancer

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

The Effects of Cancer on Family Life

Cancer Epidemiology

Assay for Monitoring and Treating Malignant Brain Tumors

Cancer Prevention: Lowering your Risk

Cancer Symptoms

Using Biomarkers to Detect Cancer

The Biochemistry of Breast Cancer Screening

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Insights into Oncofertility

Pediatric Cancer

Cancer Pain

Caring for a Loved One with Cancer

Cancer Prognosis

Extracellular Vesicles as Floating Cancer Biomarkers

The Cancer Cell Surface Proteome as a Therapeutic Target

TARDIS: The Improved Method of Detecting Breast Cancer

Insight into Cancer Vaccines

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Investigating the Molecular Mechanisms of Cancer

Cancer Research

What Role do Biobanks Play in Cancer Research?

Transforming Cancer Care through Genomic Testing

Hypoxia Markers and Their Importance

Cutaneous Manifestations of Internal Malignancy

Why are Cancer Cell Lines Useful?

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Living with Cancer Pain

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Metastatic Migration in Cancer may be Influenced by Metabolism

Cancer Pathophysiology

What Causes Cancer?

Latest Cancer News and Research

Cancer-fighting T cells need small amounts of ROS to attack tumors, study finds

New research reveals a promising new target for treating cancer by harnessing a type of molecule previously thought to do more harm than good.

3 Sep 2026

Microscopic peptide droplets reduce colorectal tumor growth in mice

Scientists from Nanyang Technological University, Singapore (NTU Singapore) have developed microscopic peptide droplets that deliver large amounts of gene-silencing molecules into cancer and immune cells, reducing the growth of hard-to-treat colorectal tumours by about 67 per cent in mice.

3 Sep 2026

Study links popular weight-loss drugs to increased male hair loss

Men already at risk genetically for the most common form of hair loss have a 7 percent added risk of losing their hair if they use drugs like Ozempic, Wegovy, and Zepbound for type 2 diabetes and obesity, a new study shows.

3 Sep 2026

IBD patients with family cancer history more likely to develop colorectal cancer

People with inflammatory bowel disease (IBD) who have several close relatives with colorectal cancer are significantly more likely to develop the disease themselves.

3 Sep 2026

Cancer drug eliminates HIV-infected cells in animal model study

Emory University researchers have provided the first proof-of-concept in a nonhuman primate model for eliminating HIV-infected cells with venetoclax, a clinically approved medication for cancer.

3 Sep 2026

Brain-protecting immune cells may actually drive Alzheimer's disease

Immune cells that normally protect the body from damage by attacking foreign or infected cells are found in the brains of patients with Alzheimer's disease and related disorders at much higher levels than in healthy brains.

3 Sep 2026

New optical imaging reveals metabolic activity of individual immune cells

A routine blood sample contains a diverse collection of immune cells that can reveal important clues about health and disease.

2 Sep 2026

High-dose folic acid appears safe from formaldehyde toxicity

Folic acid – an essential vitamin added to flour and cereals and prescribed at high doses for cancer patients and people with blood disorders – does not elevate toxic formaldehyde in the body, according to a new Cornell University study on mice and human cancer patients who consumed high doses.

2 Sep 2026

New app aims to boost prostate cancer screening among Black men

A newly funded study at the University of Oklahoma aims to increase prostate-specific antigen (PSA) screening among Black men in Oklahoma, who die from prostate cancer at rates two to four times higher than other racial groups.

2 Sep 2026

Maternal illness may reshape fetal brain development through epigenetics

Neurodevelopmental conditions, which include autism spectrum disorders, ADHD (attention-deficit/hyperactivity disorder), and more, impact around ten percent of the American population.

2 Sep 2026

Daraxonrasib shows durable responses in RAS-mutant lung cancer

Daraxonrasib, an oral RAS inhibitor therapy, achieved durable responses in pretreated patients with RAS-mutant non-small cell lung cancer (NSCLC) in a Phase 1/2 trial led by The University of Texas MD Anderson Cancer Center.

2 Sep 2026

Newly diagnosed AML patients benefit from less-intensive combination treatment

Investigators from the Mass General Brigham Cancer Institute have found that adults with newly diagnosed acute myeloid leukemia (AML) receiving a less-intensive combination of azacitidine and venetoclax had more than twice as much time before treatment failed, the leukemia returned or worsened, or they died, compared with patients receiving intensive chemotherapy.

2 Sep 2026

Alcohol-linked cancer deaths doubled over three decades in America

Alcohol-attributable cancer deaths in the U.S. doubled between 1990 and 2023, a new study found. The study also revealed that alcohol-linked cancer deaths are not limited to older adults or liver cancer.

2 Sep 2026

Mount Sinai researchers discover new radiation option for childhood brain cancer

Children with one of the deadliest forms of brain cancer may benefit from an additional course of radiation therapy after their disease returns, according to new research from the Icahn School of Medicine at Mount Sinai.

2 Sep 2026

New drug class shows major promise for shrinking nerve tumors

A scientist at Cincinnati Children's who has hunted for decades for ways to shrink the painful and disfiguring nerve tumors caused by neurofibromatosis type 1 (NF1) has made a new breakthrough in the quest.

2 Sep 2026

Two scientists win Horwitz Prize for Rett syndrome breakthrough

Columbia University will award the 2026 Louisa Gross Horwitz Prize to Adrian Bird and Huda Zoghbi for their pioneering work on epigenetic regulation in the nervous system and its role in human neurological disease, particularly Rett syndrome.

2 Sep 2026

Post-surgery immunotherapy may not benefit specific lung cancer patients

A new real-world observational study has found that adding adjuvant immunotherapy after surgery does not significantly improve survival outcomes in patients with resectable non-small cell lung cancer (NSCLC) who have already achieved a pathological complete response (pCR) following neoadjuvant chemoimmunotherapy.

2 Sep 2026